February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

Liotrix Tablets December 7, 2011 Products Affected - Description Thyrolar tablets, Forest Laboratories 12.5/3.1, 100 count (NDC 00456-0040-01) 25/6.25, 100 count (NDC 00456-0045-01) 50/12.5, 100 count (NDC 00456-0050-01) 100/25, 100 count (NDC 00456-0055-01) 150/37.5, 100 count (NDC 00456-0060-01) Reason for the Shortage Thyrolar tablets from Forest Laboratories are on back order due to manufacturing changes. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=24. Source: http://www.a ashp.org Ganciclovir Capsules December 14, 2011 Products Affected - Description Ganciclovir sodium capsules, Ranbaxy 250 mg capsules, 180 count bottles (NDC 63304-0636-28) 500 mg capsules, 180 count bottles (NDC 63304-0637-28) Reason for the Shortage Ganciclovir capsuless are on back order due to a raw material shortage.1 There are no other supplierss of ganciclovir tablets. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=539 Source: http://www.a ashp.org Choline Magnesium Trisalicylate December 16, 2011 Products Affected - Description Choline Magnesium Trisalicylate, Caraco 500 mg tablets, 100 count (NDC 57664-0219-08) - discontinued 750 mg tablets, 100 count (NDC 57664-0220-08) - discontinued 1000 mg tablets, 1000 count (NDC 57664-0221-08) - discontinued Choline Magnesium Trisalicylate, Marlex 500 mg tablets, 100 count (NDC 10135-0467-01) 750 mg tablets, 100 count (NDC 10135-0468-01) Reason for the Shortage Caraco has discontinued their product. Product was recently seized by US Marshals due to good manufacturing practice violations (see news release for more information). Marlex could not provide a reason for their shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=556 Source: http://www.a ashp.org Metronidazole tablets and capsules December 22, 2011 Products Affected - Description Metronidazole tablets, Major 250 mg, 100 count, unit dose (NDC 00904-1453-61) Metronidazole tablets, Watson 24
250 mg, 100 count (NDC 00591-3969-01) - discontinued d 250 mg tablets, 500 count (NDC 00591-3969-05) 500 mg tablets, 50 count, robot-ready (NDC 00591-3970-50) - discontinued 500 mg tablets, 500 count (NDC 00591-3970-05) Reason for the Shortage Watson states the reason for the shortage is supply constraints. Teva discontinued their metronidazole unit dose presentations. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=716 Source: http://www.a ashp.org Ticlopidine Tablets January 3, 2012 Products Affected - Description Ticlopidine tablets, Apotex 250 mg, 30 count (NDC 60505-0027-02) 250 mg, 60 count (NDC 60505-0027-04) 250 mg, 500 count (NDC 60505-0027-07) Reason for the Shortage Sandoz and Major discontinued their ticlopidine presentations in December, 2009. Par discontinued their ticlopidine presentations in January, 2009. Roche (Genentech) has discontinued Ticlid. Apotex has an import ban on their ticlopidine presentations. Caraco stopped manufacturing all ticlopidine presentations in 2009. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=661 Source: http://www.a ashp.org Prochlorperazine Edisylate Injection January 3, 2012 Products Affected - Description Prochlorperazine injection 5 mg/ /mL, Bedfordd 2 mL vial, 10 count (NDC 55390-0077-10) 10 mL vial (NDC 55390-0077-01) Reason for the Shortage Ben Venue voluntarily suspendedd all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. Bedford is the sole manufacturer r of prochlorperazine injection. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=796 Source: http://www.a ashp.org Rotigotine Transdermal Systems Patch January 4, 2012 Products Affected - Description Rotigotine transdermal systems (Neupro), UCB 2 mg/24 hours, package of 7 (NDC 00091-6486-21) 2 mg/24 hours, package of 30 (NDC 00091-6486-01) 4 mg/24 hours, package of 7 (NDC 00091-6487-21) 4 mg/24 hours, package of 30 (NDC 00091-6487-01) 25
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23: Recalling Firm: Pfizer Us Pharmaceu
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?